Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New candidate dsRNA drugs discovered at Alnylam Pharmaceuticals

July 12, 2012

Lycera patents new mitochondrial F1F0 ATPase hydrolase inhibitors

July 12, 2012

Collaboration produces novel DAPD prodrugs

July 12, 2012

Research in Norway yields new Wnt signaling inhibitors

July 12, 2012

Abbott Laboratories presents novel calpain-1 inhibitors

July 12, 2012

Research in Shanghai yields new c-Met inhibitors

July 11, 2012

GSK patents novel inhibitors of LDL-PLA2

July 11, 2012

Investigators in China develop new candidate cognition-enhancing drugs

July 11, 2012

Novel potential Gaucher's disease drugs designed in U.S.

July 11, 2012

Proteostasis Therapeutics discloses novel prosteostasis regulators

July 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...